Search Results

Cytotoxic therapies to feel sting of generics.

Subjects: *MEDICAL care; ANTINEOPLASTIC antibiotics; ANTINEOPLASTIC agentsUNITED States

• Source: PharmaWatch: Cancer. Jan2009, Vol. 8 Issue 1, p17-18. 2p.

Record details

Colorectal Cancer Update.

Subjects: COLON cancer; ANTINEOPLASTIC antibiotics; CANCER treatment

• Source: PharmaWatch: Cancer. Dec2005, Vol. 4 Issue 12, p17-18. 2p.

Record details

Roche: MabThera maintains its momentum.

Subjects: ANTINEOPLASTIC antibiotics; CLINICAL medicine; MEDICAL researchF. Hoffmann-La Roche Ltd.

• Source: PharmaWatch: Cancer. Dec2005, Vol. 4 Issue 12, p13-13. 1p.

Record details

FDA and Genentech issue warning over Avastin.

Subjects: ANTINEOPLASTIC antibiotics; CANCER chemotherapy; COLON cancerUNITED StatesGENENTECH Inc. GENENTECH Inc. GENENTECH Inc. DNA; UNITED States. Food & Drug Administration

• Source: PharmaWatch: Biotechnology. October 2004, Vol. 3 Issue 10, p12-12. 1/3p.

Record details

Appendix II Abstracts by Tumor Type.

• Authors : Porges, Geoffrey C.; Amusa, Gbola; Scannell, Jack

Subjects: ABSTRACTS; ANTINEOPLASTIC antibiotics

• Source: White Book - Global Biotechnology & Pharmaceuticals: ASCO 2006 Highlights. 6/1/2006, p107-129. 22p.

Record details

Cell Therapeutics, Inc.

Subjects: BUSINESS finance; BUSINESS cycles; INDUSTRIAL locationCELL Therapeutics Inc.

• Source: Cell Therapeutics, Inc. SWOT Analysis; Sep2008, p1-8, 8p, 2 Charts

Record details

Cancer News Round-up.

Subjects: PHARMACEUTICAL industry; CANCER; CLINICAL trialsBIOVEST International Inc.; SUNESIS Pharmaceuticals Inc.

• Source: PharmaWatch: Monthly Review; Dec2007, Vol. 6 Issue 12, p4-5, 2p

Record details

Licensing Update.

Subjects: LICENSE agreements; PHARMACEUTICAL industry; DRUGSWYETH Pharmaceuticals Inc.; ANORMED Inc.

• Source: PharmaWatch: Biotechnology; Nov2006, Vol. 5 Issue 11, p12-13, 2p

Record details

Wyeth: breast cancer prospects receive a blow.

Subjects: CLINICAL drug trials; CLINICAL trials; BREAST cancer researchWYETH (Company : 1860-2009)

• Source: PharmaWatch: Cancer; May2006, Vol. 5 Issue 5, p11-11, 2/3p

Record details

Chandra Bhagat Pharma coming with an IPO to raise up to Rs 10.20 crore.

• Source: Ace Analyser: Company News; 1/30/2020, pN.PAG-N.PAG, 1p

Record details